Submit

News

Reflections of a Lung Cancer Patient and Survivor - Tomma Hargraves

Reflections of a Lung Cancer Patient and Survivor - Tomma Hargraves

“We received the results of your biopsy on that lymph node, Mrs. Hargraves.  Would you like to come into the office?”  Thus, with that phone call from my primary care physician, my journey with lung cancer began.  After a CT scan later that day, I was officially diagnosed with stage 3B, non-small

V Foundation's new lung cancer research focuses on African-American population

V Foundation's new lung cancer research focuses on African-American population

Click here to read original article from Triangle Business Journal by Jennifer Henderson. The Lung Cancer Initiative of North Carolina and The V Foundation for Cancer Research have partnered to fund new research focused on lung cancer among the African-American population in the state. The

Lung Cancer Initiative and The V Foundation Expand Partnership to Fund Lung Cancer Research

Lung Cancer Initiative and The V Foundation Expand Partnership to Fund Lung Cancer Research

Contact: Heather Hooper  919-784-0410 hhooper@LungCancerInitiativeNC.org  Margaret Pentrack 412-337-2997 FOR IMMEDIATE RELEASE Lung Cancer Initiative and The V Foundation Expand Partnership  to Fund Lung Cancer Research  Grant Recipients Will Research Disparities Among

Cancer Services and Community Health Coalition Both Receive $5,000 Access Grants

Cancer Services and Community Health Coalition Both Receive $5,000 Access Grants

  The Lung Cancer Initiative of North Carolina is pleased to announce Cancer Services and Community Health Coalition as the recipients of 5,000 Access Grants each.  The goal of the Access Grant Program is to partner with community organizations in North Carolina to improve access to care and

FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT OF PEOPLE WITH ALK-POSITIVE NSCLC

FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT OF PEOPLE WITH ALK-POSITIVE NSCLC

FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S ALECENSA® (ALECTINIB) FOR FIRST-LINE TREATMENT OF PEOPLE WITH ALK-POSITIVE NSCLC – This Second Alecensa Breakthrough Therapy Designation Was Granted Based on Phase III J-ALEX Study  – SOUTH SAN FRANCISCO, Calif. – October 3, 2016

Mesothelioma Awareness Day

Mesothelioma Awareness Day

The other day I was in Lowe’s looking for light bulbs and an elderly man was wearing a hat with the ship he served on just like the one my grandfather wore daily.  The emotions caught me off guard.  I will miss seeing my grandfather or ‘Old Man’ wearing a similar hat.  My grandfather served over 20

10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally

10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally

Press Release  FOR IMMEDIATE RELEASE ON SEPTEMBER 14, 2016 Contact: Cynamon Frierson  Communications & Marketing Manager Lung Cancer Initiative of North Carolina (919) 669-9531 cfrierson@lungcancerinitiativenc.org   10th Annual Raleigh LUNGe Forward 5K Run, Walk & Rally September 14,

Lay Patient Navigation - Tomma Hargraves

Lay Patient Navigation - Tomma Hargraves

Lay Patient Navigation - Tomma Hargraves Tomma Hargraves, lung cancer survivor and board secretary for the Lung Cancer Initiative of North Carolina, shares with us one of the many ways that she gets involved in helping others who have received a cancer diagnosis.  The Lay Patient Navigation

ASCO Update

ASCO Update

ASCO Update In June, the American Society of Clinical Oncology (ASCO) had their annual meeting in Chicago.  They are the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.  We were pleased to have Jenni Danai, our Senior Programs

$125,000 in Grants Awarded for Lung Cancer Research in North Carolina

$125,000 in Grants Awarded for Lung Cancer Research in North Carolina

Press Release  FOR IMMEDIATE RELEASE ON JUNE 11, 2016 Contact: Cynamon Frierson  Communications & Marketing Manager Lung Cancer Initiative of North Carolina (919) 784-0410 ext. 102 cfrierson@lungcancerinitiativenc.org   125,000 in Grants Awarded for Lung Cancer Research in North Carolina

GuideStar Gold Participant